Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection

Rosa Polo Rodríguez; María José Galindo Puerto; Carlos Dueñas; Carmen Gómez Candela; Vicente Estrada; Noemí G.P. Villar; Jaime Locutura; Ana Mariño; Javier Pascua; Rosario Palacios; Miguel Ángel Von Wichmman; Julia Álvarez; Victor Asensi; José Lopez Aldeguer; Fernando Lozano; Eugenia Negredo; Enrique Ortega; Enric Pedrol; Félix Gutiérrez; Jesús Sanz Sanz; Esteban Martínez Chamorro

doi:10.1016/j.eimc.2014.05.018

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection

Rosa Polo Rodríguez, María José Galindo Puerto, Carlos Dueñas, Carmen Gómez Candela, Vicente Estrada, Noemí G.P. Villar, Jaime Locutura, Ana Mariño, Javier Pascua, Rosario Palacios, Miguel Ángel Von Wichmman, Julia Álvarez, Victor Asensi, José Lopez Aldeguer, Fernando Lozano, Eugenia Negredo, Enrique Ortega, Enric Pedrol, Félix Gutiérrez, Jesús Sanz SanzEsteban Martínez Chamorro

Department of Medicine

Research output: Contribution to journal › Article › Research › peer-review

4 Citations (Scopus)

Abstract

© 2014 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved. The importance of the metabolic disorders and their impact on patients with HIV infection requires an individualized study and continuous updating. HIV patients have the same cardiovascular risk factors as the general population. The HIV infection per se increases the cardiovascular risk, and metabolic disorders caused by some antiretroviral drugs are added risk factors. For this reason, the choice of drugs with a good metabolic profile is essential. The most common metabolic disorders of HIV infected-patients (insulin resistance, diabetes, hyperlipidemia or osteopenia), as well as other factors of cardiovascular risk, such as hypertension, should also be dealt with according to guidelines similar to the general population, as well as insisting on steps to healthier lifestyles. The aim of this document is to provide a query tool for all professionals who treat HIV-patients and who may present or display any metabolic disorders listed in this document.

Original language	English
Pages (from-to)	41-47
Journal	Enfermedades Infecciosas y Microbiologia Clinica
Volume	33
Issue number	1
DOIs	https://doi.org/10.1016/j.eimc.2014.05.018
Publication status	Published - 1 Jan 2015

Keywords

Cardiovascular risk
HIV infection
Metabolic disorders

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eimc.2014.05.018

Cite this

Rodríguez, R. P., Puerto, M. J. G., Dueñas, C., Candela, C. G., Estrada, V., Villar, N. G. P., Locutura, J., Mariño, A., Pascua, J., Palacios, R., Von Wichmman, M. Á., Álvarez, J., Asensi, V., Aldeguer, J. L., Lozano, F., Negredo, E., Ortega, E., Pedrol, E., Gutiérrez, F., ... Chamorro, E. M. (2015). Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection. Enfermedades Infecciosas y Microbiologia Clinica, 33(1), 41-47. https://doi.org/10.1016/j.eimc.2014.05.018

@article{846c11fc38e3400aa615c31317ec7623,

title = "Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection",

abstract = "{\textcopyright} 2014 Elsevier Espa{\~n}a, S.L.U. and Sociedad Espa{\~n}ola de Enfermedades Infecciosas y Microbiolog{\'i}a Cl{\'i}nica. All rights reserved. The importance of the metabolic disorders and their impact on patients with HIV infection requires an individualized study and continuous updating. HIV patients have the same cardiovascular risk factors as the general population. The HIV infection per se increases the cardiovascular risk, and metabolic disorders caused by some antiretroviral drugs are added risk factors. For this reason, the choice of drugs with a good metabolic profile is essential. The most common metabolic disorders of HIV infected-patients (insulin resistance, diabetes, hyperlipidemia or osteopenia), as well as other factors of cardiovascular risk, such as hypertension, should also be dealt with according to guidelines similar to the general population, as well as insisting on steps to healthier lifestyles. The aim of this document is to provide a query tool for all professionals who treat HIV-patients and who may present or display any metabolic disorders listed in this document.",

keywords = "Cardiovascular risk, HIV infection, Metabolic disorders",

author = "Rodr{\'i}guez, {Rosa Polo} and Puerto, {Mar{\'i}a Jos{\'e} Galindo} and Carlos Due{\~n}as and Candela, {Carmen G{\'o}mez} and Vicente Estrada and Villar, {Noem{\'i} G.P.} and Jaime Locutura and Ana Mari{\~n}o and Javier Pascua and Rosario Palacios and {Von Wichmman}, {Miguel {\'A}ngel} and Julia {\'A}lvarez and Victor Asensi and Aldeguer, {Jos{\'e} Lopez} and Fernando Lozano and Eugenia Negredo and Enrique Ortega and Enric Pedrol and F{\'e}lix Guti{\'e}rrez and Sanz, {Jes{\'u}s Sanz} and Chamorro, {Esteban Mart{\'i}nez}",

year = "2015",

month = jan,

day = "1",

doi = "10.1016/j.eimc.2014.05.018",

language = "English",

volume = "33",

pages = "41--47",

journal = "Enfermedades Infecciosas y Microbiologia Clinica",

issn = "0213-005X",

publisher = "Ediciones Doyma, S.L.",

number = "1",

}

Rodríguez, RP, Puerto, MJG, Dueñas, C, Candela, CG, Estrada, V, Villar, NGP, Locutura, J, Mariño, A, Pascua, J, Palacios, R, Von Wichmman, MÁ, Álvarez, J, Asensi, V, Aldeguer, JL, Lozano, F, Negredo, E, Ortega, E, Pedrol, E, Gutiérrez, F, Sanz, JS & Chamorro, EM 2015, 'Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection', Enfermedades Infecciosas y Microbiologia Clinica, vol. 33, no. 1, pp. 41-47. https://doi.org/10.1016/j.eimc.2014.05.018

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection. / Rodríguez, Rosa Polo; Puerto, María José Galindo; Dueñas, Carlos et al.

In: Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, No. 1, 01.01.2015, p. 41-47.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection

AU - Rodríguez, Rosa Polo

AU - Puerto, María José Galindo

AU - Dueñas, Carlos

AU - Candela, Carmen Gómez

AU - Estrada, Vicente

AU - Villar, Noemí G.P.

AU - Locutura, Jaime

AU - Mariño, Ana

AU - Pascua, Javier

AU - Palacios, Rosario

AU - Von Wichmman, Miguel Ángel

AU - Álvarez, Julia

AU - Asensi, Victor

AU - Aldeguer, José Lopez

AU - Lozano, Fernando

AU - Negredo, Eugenia

AU - Ortega, Enrique

AU - Pedrol, Enric

AU - Gutiérrez, Félix

AU - Sanz, Jesús Sanz

AU - Chamorro, Esteban Martínez

PY - 2015/1/1

Y1 - 2015/1/1

N2 - © 2014 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved. The importance of the metabolic disorders and their impact on patients with HIV infection requires an individualized study and continuous updating. HIV patients have the same cardiovascular risk factors as the general population. The HIV infection per se increases the cardiovascular risk, and metabolic disorders caused by some antiretroviral drugs are added risk factors. For this reason, the choice of drugs with a good metabolic profile is essential. The most common metabolic disorders of HIV infected-patients (insulin resistance, diabetes, hyperlipidemia or osteopenia), as well as other factors of cardiovascular risk, such as hypertension, should also be dealt with according to guidelines similar to the general population, as well as insisting on steps to healthier lifestyles. The aim of this document is to provide a query tool for all professionals who treat HIV-patients and who may present or display any metabolic disorders listed in this document.

AB - © 2014 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved. The importance of the metabolic disorders and their impact on patients with HIV infection requires an individualized study and continuous updating. HIV patients have the same cardiovascular risk factors as the general population. The HIV infection per se increases the cardiovascular risk, and metabolic disorders caused by some antiretroviral drugs are added risk factors. For this reason, the choice of drugs with a good metabolic profile is essential. The most common metabolic disorders of HIV infected-patients (insulin resistance, diabetes, hyperlipidemia or osteopenia), as well as other factors of cardiovascular risk, such as hypertension, should also be dealt with according to guidelines similar to the general population, as well as insisting on steps to healthier lifestyles. The aim of this document is to provide a query tool for all professionals who treat HIV-patients and who may present or display any metabolic disorders listed in this document.

KW - Cardiovascular risk

KW - HIV infection

KW - Metabolic disorders

U2 - 10.1016/j.eimc.2014.05.018

DO - 10.1016/j.eimc.2014.05.018

M3 - Article

SN - 0213-005X

VL - 33

SP - 41

EP - 47

JO - Enfermedades Infecciosas y Microbiologia Clinica

JF - Enfermedades Infecciosas y Microbiologia Clinica

IS - 1

ER -

Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this